___

• Grayston JT, Campbell LA, Kuo CC, Mordhorst CH, Saikku P, Thom DH, et al. A new respratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 1990;161:618-25.
• Grayston JT. Infections caused by Chlamydia pneumoniae strain TWAR. Clin Infect Dis 1992;15:757-63.
• Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and Cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
• Carlsson J, Miketic S, Brom J, Ross R, Bachmann H, Tebbe U. Prior Cytomegalovirus, Chlamydia or Helicobacter pylori infection and risk of restenosis after percutaneus transluminal coronary angioplasty. Int J Cardiology 2000;73:165-71.
• Kuo CC, Coulson AS, Campbell LA, Cappuccio AL, Lawrence RD, Wang SP, et al. Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction. J Vasc Surg 1997;26: 29-31.
• Ingalls RR, Rice PA, Qureshi N, Tkayam K, Lin JS, Golenbock DT. Inflammatory cytokine response to Chlamydia trachomatis is entotoxin mediated. Infect Immun 1995;63:3125-30.
• Heinemann M, Susa M, Simnacher U, Matte R, Essig A. Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line. Infect Immun 1996;75:573-5.
• Cabana VG, Siegel JN, Sabesin SM. Effects of the acute phase response on the concentration and density distribution of plasma lipids and lipoproteins. J Lipid Res 1989;30:39-49.
• Ernst E. Fibrinogen as a cardiovascular risk factor-interrelationship with infection and inflammation. Eur Heart J 1993;4:82-7. In: Leinonen M. Chlamydia pneumoniae and other risk factors for atherosclerosis. J Infect Dis 2000;181:414-6.
• Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, Makela PH, et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988;2:983-6.
• Saikku P, Leinonen M, Tenkanen L, Linnanmaki E, Ekman MR, Manninen V, et al. Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med 1992;116:273-8.
• Miettinen H, Lehto S, Saikku P. Association of Chlamydia pneumoniae and acute coronary heart disease in non-insulin-dependent diabetic and non-diabetic subjects in Finland. Eur Heart J 1996;17:682-8.
• Hoffmeister A, Rothenbacher D, Wanner P, Bode G, Persson K, Brenner H, et al. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study. J Am Coll Cardiol 2000;35:112-8.
• Kark JD, Leinonen M, Paltiel O, Saikku P. Chlamydia pneumoniae and acute myocard infarction in Jarusalem. Int J Epidemiol 1997;26:730-8.
• Ossewaarde JM, Feskens EJ, De Vries A, Vallinga CE, Kromhout D. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and Cytomegalovirus are not. Epidemiol Infect 1998;120:93-9.
• Shor A, Kuo CC, Patto DL. Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques. S Afr Med J 1992;82:158-61.
• Kuo CC, Shor A, Campbell LA, Fukushi H, Patton DL, Grayston JT. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J Infect Dis 1993;167:841-9.